Identification of metabolic reprogramming-related key genes in hepatocellular carcinoma after transcatheter arterial chemoembolization treatment
Our study provided systematic insights into identification of biomarkers for TACE treatment sensitivity in HCC.
Authors
- Tongfei Li (ORCID: https://orcid.org/0000-0001-5520-0921)
- Shan Sun (ORCID: https://orcid.org/0000-0003-2142-4307)
- Shengjun Wang (ORCID: https://orcid.org/0000-0001-6584-1183)
- Yong Zhang (ORCID: https://orcid.org/0000-0002-1303-0458)
- Shujuan Liu (ORCID: https://orcid.org/0000-0002-4900-9669)
- Mingliang Li (ORCID: https://orcid.org/0000-0001-6201-2232)
- Feng Ji (ORCID: https://orcid.org/0000-0002-6943-2624)
Institutions
- Xian Central Hospital (CN)
- Jilian Technology Group (China) (CN)
- Fourth People’s Hospital of Jinan (CN)
- Affiliated Hospital of Taishan Medical University (CN)
- Jinan City People's Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1007/s12672-025-02606-z
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42